A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  1998-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V92.4.1119.416K39_1119_1124PMID 9694698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Geographic Distribution of the 20210 G to A Prothrombin Variant

  1998cited by this paper
• Frequencies of prothrombin 20210 G-->A mutation may be different among races--studies on Japanese populations with various forms of thrombotic disorders and healthy subjects.

  1998cited by this paper
• Thrombophilia as a multigenic disorder.

  1998cited by this paper
• The 20210 A Allele of the Prothrombin Gene Is a Common Risk Factor among Swedish Outpatients with Verified Deep Venous Thrombosis

  1997cited by this paper
• Thrombophilia as a Multigenic Disorder

  1997cited by this paper
• The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population

  1997cited by this paper
• A single genetic origin for a common Caucasian risk factor for venous thrombosis.

  1997cited by this paper
• Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin gene

  1997cited by this paper
• A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

  1996cited by this paper
• World distribution of factor V Leiden.

  1996cited by this paper
• Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia.

  1996cited by this paper
• A point mutation (Arg271→Cys) of a homozygote for dysfunctional prothrombin, prothrombin Obihiro, which has a region of high sequence variability

  1995cited by this paper
• World distribution of factor V Leiden.

  1995cited by this paper
• Activated protein C resistance caused by Arg506Gln mutation in factor Va.

  1994cited by this paper
• Resistance to activated protein C as a basis for venous thrombosis.

  1994cited by this paper
• Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

  1994cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

  1993cited by this paper
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

  1993cited by this paper
• Anticoagulant protein C pathway defective in majority of thrombophilic patients.

  1993cited by this paper
• Highly polymorphic region of the human prothrombin (F2) gene

  1992cited by this paper
• Characterization of the Alu-rich 5'-flanking region of the human prothrombin-encoding gene: identification of a positive cis-acting element that regulates liver-specific expression.

  1990cited by this paper
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

  1989cited by this paper
• Human genes encoding prothrombin and ceruloplasmin map to 11p11–q12 and 3q21–24, respectively

  1987cited by this paper
• Nucleotide sequence of the gene for human prothrombin.

  1987cited by this paper

• Are there disparities in cerebral sinus venous thrombosis between the Arab and Jewish populations in Israel - a multicenter cohort study?

  2026cites this paper
• Polymorphisms in FVL, prothrombin, and MTHFR genes in samples tested for thrombophilia in Saudi Arabia

  2025influential citation
• Efficacy and safety of anti-Xa direct oral anticoagulants vs. warfarin in patients homozygous for Factor V Leiden and prothrombin G20210A mutations

  2025influential citation
• Clinical Outcomes and Healthcare Utilization in Pulmonary Embolism Patients With and Without Prothrombin G20210A Mutation: A National Retrospective Cohort Study

  2025cites this paper
• Impact of thrombophilia on venous thromboembolism management.

  2024cites this paper
• Preoperative incidence and risk factors of deep vein thrombosis in Japanese patients undergoing total hip arthroplasty

  2023cites this paper
• Prothrombin Gene Mutation as a Teaching Tool: An Autobiographical Case Report

  2023cites this paper
• Central retinal artery occlusion and subsequent amaurosis fugax in the contralateral eye associated with the G20210A prothrombin gene (F2) variant: a case report

  2022cites this paper
• Thrombotic and Atherogenetic Predisposition in Polyglobulic Donors

  2022cites this paper
• Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review

  2022cites this paper
• Prevalence of positive factor V Leiden and prothrombin mutations in samples tested for thrombophilia in Saudi Arabia.

  2021cites this paper
• Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity

  2020cites this paper
• Congenital and Acquired Hypercoagulable States

  2020cites this paper
• Great Obstetrical Syndromes In G20210a Mutation Carriers Associated With High Prothrombin Activity

  2020cites this paper
• Evolving paradigm in thrombophilia screening

  2019cites this paper
• Hereditary and Acquired Causes of a Hypercoagulable State

  2019cites this paper
• Vitamin K-dependent protein S: Function and etiological significance

  2019cites this paper
• Thrombophilia

  2019cites this paper
• Triple thrombophilic simultaneous mutations in patients after bariatric surgery: is there a role for screening in the Eastern Mediterranean?

  2018cites this paper
• Stratifying Thromboembolic Risk: Why Is Your Patient on Antithrombotic Medications?

  2018cites this paper
• Secondary Thromboprophylaxis in Hereditary Thrombophilia

  2018cites this paper
• Congenital Factor VII Deficiency

  2018cites this paper
• Deep Vein Thrombosis Prophylaxis after Total Hip Arthroplasty in Asian Patients

  2018cites this paper
• Acquired and Genetic Thrombotic Risk Factors in the Athlete

  2018cites this paper
• Triple thrombophilic simultaneous mutations in patients after bariatric surgery: is there a role for screening in the Eastern Mediterranean?

  2018cites this paper
• Common Prothrombotic Gene Mutations in Cerebral Venous Sinus Thrombosis in North-West of Iran

  2017cites this paper
• 1 Inherited Thrombophilia : Past , Present , and Future Research

  2017cites this paper
• Global prevalence of prothrombin gene mutation G20210A and implications in women's health: a systematic review

  2016cites this paper
• Prevalence of thrombophilia and thrombotic events in patients with fabry disease in a Reference Center for Lysosomal Disorders in Southern Brazil

  2016cites this paper
• Venous thromboembolism with special focus on genetic and potential acquired risk factors

  2016cites this paper
• Identification of Thrombosis Modifier Genes Using ENU Mutagenesis in the Mouse.

  2016cites this paper
• Evaluation of the Association Between Hereditary Thrombophilias and Recurrent Pregnancy Loss

  2016cites this paper
• Impact of Prothrombotic Risk Factors in a Cohort of Egyptian Hemophilia A Patients

  2016cites this paper
• Pediatric thromboembolism: a national survey in Japan

  2016cites this paper
• Epidemiology of prothrombin G20210A polymorphism in the Southern Iran

  2015cites this paper
• Therapeutic Advances in Neurological Disorders

  2015cites this paper
• Clinical Performance of the 1st American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism after Total Knee Arthroplasty in Korean Patients

  2015cites this paper
• “ 20209 C-T ” a Variant Mutation of Prothrombin Gene Mutation in a Patient with Recurrent Pregnancy Loss

  2014cites this paper
• The 3'end prothrombin gene variants in patients with different thrombotic events.

  2014cites this paper
• "20209C-T" a variant mutation of prothrombin gene mutation in a patient with recurrent pregnancy loss.

  2014cites this paper
• Venous intestinal ischemia due to G20210A mutation of prothrombin gene.

  2013cites this paper
• Analysis of factor V Leiden and prothrombin mutations in patients with suspected thrombophilia in São Paulo state-Brazil Análise da mutação no fator V de Leiden e na protrombina em pacientes do estado de São Paulo, Brasil

  2013cites this paper
• Genetics and Molecular Pathophysiology of Thrombotic States

  2013cites this paper
• MTHFR Polymorphic Variant C677T Is Associated to Vascular Complications in Sickle-Cell Disease

  2012cites this paper
• Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan

  2012cites this paper
• Identification of an ancient haemophilia A splice site mutation.

  2012cites this paper
• Pregnancy loss and thrombophilia: the elusive link

  2012cites this paper
• The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia

  2012cites this paper
• Autosomal-dominant inheritance of the prothrombin gene mutation in a Puerto Rican family: A case study.

  2012cites this paper
• Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation.

  2011cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Epidemiology of Prothrombin G20210a High Prevalence of Prothrombin G20210a Mutation Was Reported in Caucasian Populations, but the Prevalence Was Almost absent in Non Europe and the Mediterranean Region. This Review Article Discusses Prothr

  2011cites this paper
• EVALUATION OF HIGH-THROUGHPUT METHODOLOGY FOR MULTI-GENE SCREENING IN PATIENTS WITH NON- ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

  2011cites this paper
• Triple heterozygous thrombophilic Mutations : a family study : peer reviewed case study

  2011cites this paper
• Thrombosis risk in carriers of the factor V Leiden mutation: is it associated with a defined skin color?

  2011cites this paper
• Genetic predictors of response to photodynamictherapy.

  2011cites this paper
• Inherited Thrombophilia: Past, Present, and Future Research

  2011cites this paper
• Thrombophilic screening in Turner syndrome

  2011cites this paper
• Genetic Predictors of Response to Photodynamic Therapy

  2011cites this paper
• Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis

  2010cites this paper
• mRNA amount and expression in a stable reporter gene assay system efficiency and modulates effects of the 20210G>A polymorphism on The intronic prothrombin 19911A>G polymorphism influences splicing

  2010cites this paper
• Venous thromboembolism in African-Americans: a literature-based commentary.

  2010cites this paper
• Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolate reductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco

  2010cites this paper
• Menopause and Ovarian Reserve: Genetic and Clinical Aspects

  2010cites this paper
• Factor V Leiden mutation and pregnancy. Haemostasis during pregnancy in non-carriers and carriers of factor V Leiden mutation, with special emphasis on placenta-mediated and venous thromboembolic complications and on blood coagulation and fibrinolysis markers for prediction of complications

  2009cites this paper
• Low prevalence of Factor V Leiden and the prothrombin G20210A mutation in a healthy population from the central-south region of Chile

  2009cites this paper
• Prospective, sequential, longitudinal study of coagulation changes during pregnancy in Chinese women

  2009cites this paper
• Clinical and laboratory management of the prothrombin G20210A mutation.

  2009cites this paper
• Prevalence of the prothrombin G20210A polymorphism in the Lebanese population: use of a reverse hybridization strip assay approach

  2009cites this paper
• Factor V Leiden mutation and pregnancy

  2009cites this paper
• High Incidence of Factor V Leiden and Prothrombin G20210A in Healthy Southern Italians

  2009cites this paper
• Prothombin gene G20210A mutation is not a risk factor for ischemic stroke in a South Indian Hyderabadi Population.

  2009cites this paper
• Chapter 9 – Hemostatic Disorders Presenting as Cerebral Infarction

  2009cites this paper
• Genetic variations and their influence on risk and treatment of venous thrombosis.

  2008cites this paper
• The association between vascular function-related genes and age at natural menopause

  2008cites this paper
• Protrombina mutante em indivduos sob investigao de trombofilia

  2008cites this paper
• Portal Vein Thrombosis: An Unexpected Finding in a 28-Year-Old Male With Abdominal Pain

  2008cites this paper
• Thrombophilic polymorphisms in Israel.

  2008cites this paper
• The Frequency of Factor V Leiden and Concomitance of Factor V Leiden With Prothrombin G20210A Mutation and Methylene Tetrahydrofolate Reductase C677T Gene Mutation in Healthy Population of Denizli, Aegean Region of Turkey

  2007cites this paper
• Factors leading to decreased rates of deep vein thrombosis and pulmonary embolism after total knee arthroplasty.

  2007cites this paper
• THE 2007 JOHN CHARNLEY AWARD: Factors Leading to Low Prevalence of DVT and Pulmonary Embolism after THA: Analysis of Genetic and Prothrombotic Factors

  2007cites this paper
• Should thromboprophylaxis be used in hereditary thrombophilias with RPL? -Against

  2007cites this paper
• Cerebral venous sinus thrombosis as a recurrent thrombotic event in a patient with heterozygous prothrombin G20210A genotype after discontinuation of oral anticoagulation therapy: How long should we treat these patients with warfarin?

  2007cites this paper
• The scientific basis for evaluation and management of thrombotic disorders.

  2006cites this paper
• The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population‐based case–control study

  2006cites this paper
• Thrombophilic gene polymorphisms in puerperal cerebral veno-sinus thrombosis.

  2006cites this paper
• The prothrombin 20209 C→T mutation in Jewish‐Moroccan Caucasians: molecular analysis of gain‐of‐function of 3′ end processing

  2006cites this paper
• Prothrombin G20210A and A19911G mutations in Turkish pediatric stroke patients.

  2006cites this paper
• Hereditary thrombophilia

  2006cites this paper
• Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype. A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

  2006cites this paper
• Iliofemoral deep vein thrombosis in childhood; developing a management protocol.

  2006cites this paper
• Prevalence of hereditary risk factors for thrombophilia in Belém

  2006cites this paper
• Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago.

  2006cites this paper
• Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics.

  2005cites this paper
• Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.

  2005cites this paper
• Haemophilia A: from mutation analysis to new therapies

  2005cites this paper
• Genetic Testing for Thrombophilia Mutations

  2005cites this paper
• Trombophilic screening for nonarteritic anterior ischemic optic neuropathy

  2005cites this paper
• Prothrombin 20210A Allele May Not Be an Independent Risk Factor for Myocardial Infarction

  2005cites this paper
• Trombofilia, ¿cuándo, qué pruebas y a quién?

  2005cites this paper
• Genetic testing for thrombophilia mutations.

  2005cites this paper